Citadel Advisors
FMI

Citadel Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Citadel Advisors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-20,700
Closed -$2.83M – 10082
2018
Q2 		$2.83M Sell
20,700
-1,900
-8% -$173K ﹤0.01% 3567
2018
Q1 		$1.78M Buy
22,600
+4,300
+23% +$317K ﹤0.01% 3909
2017
Q4 		$1.25M Buy
+18,300
New +$949K ﹤0.01% 4336
2017
Q2 		– Sell
-6,800
Closed -$219K – 8437
2017
Q1 		$219K Buy
+6,800
New +$170K ﹤0.01% 6372
2016
Q1 		– Sell
-5,000
Closed -$105K – 8691
2015
Q4 		$105K Buy
+5,000
New +$96.4K ﹤0.01% 6627
2015
Q2 		– Sell
-9,600
Closed -$462K – 9309
2015
Q1 		$462K Buy
9,600
+2,500
+35% +$113K ﹤0.01% 5020
2014
Q4 		$158K Sell
7,100
-2,900
-29% -$66.9K ﹤0.01% 6242
2014
Q3 		$190K Buy
10,000
+3,700
+59% +$88.2K ﹤0.01% 5781
2014
Q2 		$170K Sell
6,300
-6,100
-49% -$155K ﹤0.01% 5737
2014
Q1 		$401K Buy
+12,400
New +$403K ﹤0.01% 4663

Citadel Advisors's FMI Position: Q2 2018 in Review

Citadel Advisors sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 8,391 shares — an estimated $762K sold.

Citadel Advisors first reported a position in FMI in Q3 2013 and held it in 10 quarters. The position peaked at $20.9M in Q3 2013. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.

  • Citadel Advisors reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
  • Citadel Advisors sold 8,391 Foundation Medicine, Inc. shares in Q2 2018, an estimated $762K.
  • Citadel Advisors first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 10 quarters.
  • Citadel Advisors's Foundation Medicine, Inc. position peaked at $20.9M in Q3 2013.
  • 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.